Volvo Cars Q4 2025: turnaround plan on track, but challenging external environment

Volvo Cars Q4 2025: turnaround plan on track, but challenging external environment

GOTHENBURG, Sweden, Feb. 5, 2026 /PRNewswire/ -- Volvo Cars' financial report for the fourth quarter and full year 2025. Q4 revenue was SEK 94.4 bn (SEK 112.1 bn in Q4 2024) Q4 operating income was SEK 1.9 bn (SEK 3.9 bn in Q4 2024) Q4 operating...

Global Mind Australia and Farmacist enter strategic partnership to advance precision, sustainable agriculture from Australia to ASEAN

Global Mind Australia and Farmacist enter strategic partnership to advance precision, sustainable agriculture from Australia to ASEAN

BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ -- through Global Mind Australia (GMAA), AgriS (Thanh Thanh Cong – Bien Hoa Joint Stock Company, HOSE: SBT) and Farmacist, the largest independent agronomic service provider and advisory firm in the...

Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis

Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis

HONG KONG, Jan. 19, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced that its supplemental New Drug Application (sNDA) for gumokimab (AK111), a novel humanized anti-IL-17A monoclonal antibody for the treatment of active ankylosing spondylitis...

CNP Global Reignites the K-Kids Red Ginseng Beverage Category in Vietnam

CNP Global Reignites the K-Kids Red Ginseng Beverage Category in Vietnam

SEOUL, South Korea, Jan. 19, 2026 /PRNewswire/ -- CNP Global Co., Ltd. is a specialized development and outsource manufacturing company that develops beverages for children for both domestic and international markets. Aligned with its corporate...

Kia Unveils EV2 at Brussels Motor Show

Kia Unveils EV2 at Brussels Motor Show

The Kia EV2 – the brand's sixth dedicated electric model – debuts at the 2026 Brussels Motor Show Compact B-SUV designed to support diverse modern lifestyles, delivering class-above interior space and an emotionally engaging electric driving...

Leveraging Enamel Technology for Entry into Space Industry Space Project Launched

Leveraging Enamel Technology for Entry into Space Industry Space Project Launched

OSAKA, Japan, Dec. 25, 2025 /PRNewswire/ -- Takara Standard Inc. (Headquarters: Joto-ku, Osaka; President and CEO: Dai Komori), a manufacturer of residential equipment centered on system kitchens and baths, has launched its "Space Project." This...

VetMew, the AI-powered Pet Health Support App, Officially Launches in North American Market

VetMew, the AI-powered Pet Health Support App, Officially Launches in North American Market

BOSTON, Dec. 18, 2025 /PRNewswire/ -- VetMew, an AI-powered pet health support application, today announced its official launch in the North American market. The app delivers a groundbreaking tool designed to empower pet owners with immediate,...

Agricultural Corporation Joeunsul Co., Ltd. Announces Entry into Vietnam Market, Accelerating Southeast Asia Expansion with "Cheonbihyang"

Agricultural Corporation Joeunsul Co., Ltd. Announces Entry into Vietnam Market, Accelerating Southeast Asia Expansion with "Cheonbihyang"

SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- Korean traditional liquor producer Agricultural Corporation Joeunsul Co., Ltd. has announced its plans to enter the Vietnamese market, spearheading its Southeast Asia expansion with its flagship...

OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases

OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases

Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and strong drug discovery capabilities, to discover and develop novel therapeutics for multiple...

Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006

Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006

HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio today announced Formation Bio's acquisition of worldwide rights, excluding...

  • 1
  • 2
  • 3
  • 4
  • menu
    menu